Top

Published in:

01-03-2011 | SSAT/AHPBA Joint Symposium 2010

Prognostic Markers and Staging Systems for Patients with Colorectal Liver Metastases

Authors: James J. Mezhir, Michael I. D’Angelica

Published in: Journal of Gastrointestinal Surgery | Issue 3/2011

Excerpt

The treatment of colorectal liver metastasis has evolved over the last 20 years. What was previously thought to be a contraindication to surgery metastatic disease in the liver has been demonstrated to be amenable to locoregional therapy. Up to 70% of recurrences after resection of primary colorectal cancer occur in the liver and up to 40% of these patients present with liver-only disease. These patients are amenable to potential cure following metastasectomy as demonstrated by 10 year actual survival of nearly 20% in selected patients.1 …

Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007; 25(29):4575–80.PubMedCrossRef

Rees M, Tekkis PP, Welsh FK, et al. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247(1):125–35.PubMedCrossRef

Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1,001 consecutive cases. Ann Surg 1999; 230(3):309–18; discussion 318–21.PubMedCrossRef

Iwatsuki S, Dvorchik I, Madariaga JR, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 1999; 189(3):291–9.PubMedCrossRef

Zakaria S, Donohue JH, Que FG, et al. Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg 2007; 246(2):183–91.PubMedCrossRef

Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 2008; 359(17):1757–65.PubMedCrossRef

Kattan MW, Gonen M, Jarnagin WR, et al. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg 2008; 247(2):282–7.PubMedCrossRef

Reddy SK, Kattan MW, Yu C, et al. Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases. HPB (Oxford) 2009; 11(7):592–9.

Gallagher DJ, Zheng JT, Capanu M, et al. Response to Neoadjuvant Chemotherapy Does Not Predict Overall Survival for Patients With Synchronous Colorectal Hepatic Metastases. Annals of Surgical Oncology 2009; 16(7):1844–1851.PubMedCrossRef

10.

Katz SC, Pillarisetty V, Bamboat ZM, et al. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases. Ann Surg Oncol 2009; 16(9):2524–30.PubMedCrossRef

Title: Prognostic Markers and Staging Systems for Patients with Colorectal Liver Metastases
Authors: James J. Mezhir
Michael I. D’Angelica
Publication date: 01-03-2011
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 3/2011
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-011-1424-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prognostic Markers and Staging Systems for Patients with Colorectal Liver Metastases

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2011

Laparoscopic Appendectomy for Amyand’s Hernia: A Modern Approach to A Historic Diagnosis

Nissen Fundoplication after Failure of Endoluminal Fundoplication: Short-Term Results

Erratum to: Predicting Organ Space Surgical Site Infection with a Nomogram

High-Throughput Mutation Profiling in Intraductal Papillary Mucinous Neoplasm (IPMN)

Surgery for Hilar Cholangiocarcinoma: A Multi-institutional Update on Practice and Outcome by the AFC-HC Study Group

The Role of Peri-operative Chemotherapy for Resectable Colorectal Liver Metastasis: What Does the Evidence Support?